Cargando…

Recent Advances in Genetic Predisposition of Myasthenia Gravis

Myasthenia gravis (MG) is an autoimmune disease mediated by the presence of autoantibodies that bind to components of the neuromuscular junction, causing the symptoms of muscular weakness and fatigability. Like most autoimmune disorders, MG is a multifactorial, noninherited disease, though with an e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zagoriti, Zoi, Kambouris, Manousos E., Patrinos, George P., Tzartos, Socrates J., Poulas, Konstantinos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835684/ https://www.ncbi.nlm.nih.gov/pubmed/24294607 http://dx.doi.org/10.1155/2013/404053

Ejemplares similares

Genetics of Myasthenia Gravis: A Case-Control Association Study in the Hellenic Population
por: Zagoriti, Zoi, et al.
Publicado: (2012)

Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis Patients
por: Kordas, Gregory, et al.
Publicado: (2014)

Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management
por: Lazaridis, Konstantinos, et al.
Publicado: (2020)

Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics
por: Lazaridis, Konstantinos, et al.
Publicado: (2020)

VAV1 and BAFF, via NFκB pathway, are genetic risk factors for myasthenia gravis
por: Avidan, Nili, et al.
Publicado: (2014)

Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK
por: Yilmaz, Vuslat, et al.
Publicado: (2015)

Expression of a Highly Antigenic and Native-Like Folded Extracellular Domain of the Human α1 Subunit of Muscle Nicotinic Acetylcholine Receptor, Suitable for Use in Antigen Specific Therapies for Myasthenia Gravis
por: Niarchos, Athanasios, et al.
Publicado: (2013)

Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease
por: Vakrakou, Aigli G., et al.
Publicado: (2023)

PheWAS and cross-disorder analysis reveal genetic architecture, pleiotropic loci and phenotypic correlations across 11 autoimmune disorders
por: Topaloudi, Apostolia, et al.
Publicado: (2023)

Recent advances in understanding and managing myasthenia gravis
por: Jordan, Allison, et al.
Publicado: (2018)

Common Denominators in the Immunobiology of IgG4 Autoimmune Diseases: What Do Glomerulonephritis, Pemphigus Vulgaris, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura and Autoimmune Encephalitis Have in Common?
por: Koneczny, Inga, et al.
Publicado: (2021)

IL-6 and Akt are involved in muscular pathogenesis in myasthenia gravis
por: Maurer, Marie, et al.
Publicado: (2015)

Microcurrent Stimulation Triggers MAPK Signaling and TGF-β1 Release in Fibroblast and Osteoblast-Like Cell Lines
por: Konstantinou, Evangelia, et al.
Publicado: (2020)

A Striational Muscle Antigen and Myasthenia Gravis-Associated Thymomas Share an Acetylcholine-Receptor Epitope
por: Marx, Alexander, et al.
Publicado: (1992)

A Recombinant Acetylcholine Receptor α1 Subunit Extracellular Domain Is a Promising New Drug Candidate for Treatment Of Myasthenia Gravis
por: Lazaridis, Konstantinos, et al.
Publicado: (2022)

Immunological and Structural Characterization of Titin Main Immunogenic Region; I110 Domain Is the Target of Titin Antibodies in Myasthenia Gravis
por: Stergiou, Christos, et al.
Publicado: (2023)

Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors — Recommendations for methods and experimental designs
por: Losen, Mario, et al.
Publicado: (2015)

Wireless Direct Microampere Current in Wound Healing: Clinical and Immunohistological Data from Two Single Case Reports
por: Lagoumintzis, George, et al.
Publicado: (2019)

Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011)

Editorial: Advances in Autoimmune Myasthenia Gravis
por: Punga, Anna Rostedt, et al.
Publicado: (2020)

Advances and challenges in the treatment of myasthenia gravis
por: Schneider-Gold, Christiane, et al.
Publicado: (2021)

Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007)

Myasthenia Gravis
Publicado: (1905)

Myasthenia Gravis
por: Wilson, Andrew
Publicado: (1952)

Myasthenia Gravis
por: Bramwell, Edwin
Publicado: (1901)

Thymectomy for myasthenia gravis
por: Moorehead, R J, et al.
Publicado: (1985)

Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient
por: Saxena, Abhishek, et al.
Publicado: (2017)

Myasthenia Gravis with Elderly Onset at Advanced Age
por: Hernandez Fustes, Otto Jesus, et al.
Publicado: (2020)

Thymectomy in Myasthenia Gravis
por: Dunlop, D. M.
Publicado: (1953)

Thymectomy in Myasthenia Gravis
por: Brown, K. Paterson
Publicado: (1953)

Thymectomy for Myasthenia Gravis
por: Keynes, Geoffrey
Publicado: (1949)

The epidemiology of myasthenia gravis
por: Bubuioc, Ana-Maria, et al.
Publicado: (2021)

Diagnosis of Myasthenia Gravis
por: Rousseff, Rossen T.
Publicado: (2021)

Afterdischarges in Myasthenia Gravis
por: Yang, Li, et al.
Publicado: (2021)

Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis
por: Townsel, Courtney, et al.
Publicado: (2016)

Psychometric Properties of the Quantitative Myasthenia Gravis Score and the Myasthenia Gravis Composite Scale
por: Barnett, Carolina, et al.
Publicado: (2015)

Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
por: Farsalinos, Konstantinos, et al.
Publicado: (2020)

Real-Time Assessment of E-Cigarettes and Conventional Cigarettes Emissions: Aerosol Size Distributions, Mass and Number Concentrations
por: Lampos, Spyros, et al.
Publicado: (2019)

An update on treatments in myasthenia gravis
por: Jones, Lliwen A., et al.
Publicado: (2016)

Clinical trials in myasthenia gravis
por: Mahmood, A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_alt5p3r3tjhgvaimcb09ti7m1o